InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Moore Matthew Richard, SVP et Directeur des Affaires. Director active across 1 company, notably Arcutis Biotherapeutics, Inc.. Cumulatively, 6 disclosures have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €59k. History available since 3 March 2022. The latest transaction was filed on 1 May 2024 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Moore Matthew Richard is SVP et Directeur des Affaires at Arcutis Biotherapeutics, Inc. Across 6 filings in total, the 6 sampled filings run from 2022-03-07 to 2024-05-03, with EUR 0 in purchases and EUR 59129 in sales, and the modal transaction nature is Attribution.